Evidence map›Paper›PMID 36175462›Full record

ArticleScientific reports2022

Colitis-associated intestinal microbiota regulates brain glycine and host behavior in mice.

Maryana V Morozova, Mariya A Borisova, Olga A Snytnikova, Kseniya M Achasova, Ekaterina A Litvinova, Yuri P Tsentalovich, Elena N Kozhevnikova

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Underneath the Gut-Brain Axis in IBD-Evidence of the Non-Obvious.International journal of molecular sciences · 2024
    Review
  12. Article
  13. Restoration ofInternational journal of molecular sciences · 2024
    Article
  14. Article
  15. Pharmaceutics · 2023
    Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

Maryana V Morozova *Scientific Research Institute of Neurosciences and Medicine (SRINM), Novosibirsk, 630117, Russian Federation.
Mariya A Borisova *The Federal Research Center Institute of Cytology and Genetics SB RAS, Novosibirsk, Russian Federation.
Olga A SnytnikovaInternational Tomography Center SB RAS, Novosibirsk, Russian Federation.
Kseniya M AchasovaScientific Research Institute of Neurosciences and Medicine (SRINM), Novosibirsk, 630117, Russian Federation.
Ekaterina A LitvinovaScientific Research Institute of Neurosciences and Medicine (SRINM), Novosibirsk, 630117, Russian Federation.
Yuri P TsentalovichInternational Tomography Center SB RAS, Novosibirsk, Russian Federation.
Elena N KozhevnikovaScientific Research Institute of Neurosciences and Medicine (SRINM), Novosibirsk, 630117, Russian Federation. kozhevnikovaen@physiol.ru.
International Tomography Center · RUInstitute of Cytology and Genetics · RUInstitute of Molecular and Cell Biology · RUNovosibirsk State Agricultural University · RUNovosibirsk State Technical University · RUSiberian Branch of the Russian Academy of Sciences · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammatory bowel diseases (IBD) are chronic and relapsing inflammatory disorders of the gastrointestinal tract with complex etiology and no strategies for complete cure. IBD are often complicated by mental disorders like anxiety and depression, indicating substantial shifts in the microbiota gut-brain axis. However, the mechanisms connecting IBD to mental diseases are still under debate. Here we use Muc2 knockout mouse model of chronic colitis to uncouple the effects of the intestinal microbiota on host behavior from chronic inflammation in the gut. Muc2 knockout male mice exhibit high exploratory activity, reduced anxiety-related behaviors, impaired sensorimotor gating, and altered social preference towards males and females. Microbial transfer to wild-type mice via littermate co-housing shows that colitis-associated microbiota rather than inflammation per se defines behavioral features in Muc2 colitis model. Metagenomic profiling and combination of antibiotic treatments revealed that bacterial species Akkermansia muciniphila is associated with the behavioral phenotype in mutants, and that its intestinal abundance correlates with social preference towards males. Metabolomic analysis together with pharmacological inhibition of Gly and NMDA receptors helped us to determine that brain glycine is responsible for the behavioral phenotype in Muc2 mice. Blood and brain metabolic profiles suggest that microbiota-dependent changes in choline metabolism might be involved in regulation of central glycine neurotransmission. Taken together, our data demonstrates that colitis-associated microbiota controls anxiety, sensorimotor gating and social behavior via metabolic regulation of the brain glycinergic system, providing new venues to combat neurological complications of IBD.

Indexed as

ColitisFabaceaeGastrointestinal MicrobiomeInflammatory Bowel DiseasesAnimalsBrainCholineFemaleGlycineInflammationMaleMiceReceptors, N-Methyl-D-AspartateCholineGlycineReceptors, N-Methyl-D-Aspartate

Identifiers

PMID36175462
PMCPMC9522854
OpenAlexW4297988181

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.